1, 2, 4 -oxadiazole derivatives and their therapeutic use

Details for Australian Patent Application No. 2009331959 (hide)

Owner Almirall S.A.

Inventors Giulio Matassa, Victor; Aguilar Izquierdo, Nuria; Mir Cepeda, Marta; Carrascal Riera, Marta; Fonquerna Pou, Silvia; Cardus Figueras, Aranzazu; Castro Palomino Laria, Julio Cesar; Erra Sola, Montserrat

Agent Davies Collison Cave

Pub. Number AU-A-2009331959

PCT Pub. Number WO2010/072352

Priority 08382090.2 26.12.08 EP

Filing date 15 December 2009

Wipo publication date 1 July 2010

International Classifications

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/4245 (2006.01) - Oxadiazoles

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

30 June 2011 PCT application entered the National Phase

  PCT publication WO2010/072352 Priority application(s): WO2010/072352

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009331961-Mesylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)he xyl]amino }-1-hydroxyethyl)-8-hydroxyquinolin-2(1 H)-one as agonist of the beta2 adrenergic receptor

2009331956-Measurement apparatus for vacuum therapy systems for wound treatment